Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixazomib in HIV infected patients
NCT02946047Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Mar 2017
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixazomib in human immunodeficiency virus infection (HIV), sponsored by Mayo Clinic. Started Mar 2017; status: completed.
02
Drugs
ixazomib
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02946047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02946047.